Chen, S <br/><br/>
The cytochrome P450 2D6 (CYP2D6) enzyme polymorphism: screening costs and influence on clinical outcomes in psychiatry.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  Nov 1996 
 - 522-34 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0009-9236 
<br/><br/><label>Standard No.: </label>10.1016/S0009-9236(96)90148-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antidepressive Agents, Tricyclic--therapeutic use<br/>Cytochrome P-450 CYP2D6--genetics<br/>DNA--isolation & purification<br/>Depression--drug therapy<br/>Genetic Testing--economics<br/>Genotype<br/>Humans<br/>Polymerase Chain Reaction--standards<br/>Polymorphism, Genetic--genetics<br/>Quality Control<br/>Reagent Kits, Diagnostic--standards<br/>Reproducibility of Results